Wave Life Sciences Ltd. (WVE) Insider Trading

Over the last 3 months, WVE insiders made 4 open-market buys and 0 sales, a net purchase of $54.6M (SEC Form 4). Over the last 6 months, 204 institutions increased and 93 reduced their position (13F).

Insider Activity

Sentiment
100/100
Buys (3m)
4
Sells (3m)
0
Net (3m)
$54.6M
Insiders buying
Insider trades by month Buys Sells
Aug
Nov
Dec
Jan
Feb
Mar
Context3-month price -58%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Mar 30, 2026RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Buy971,091$6.50
Mar 30, 2026RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Buy351,224$6.38
Mar 30, 2026RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Buy4,954,558$6.06
Mar 30, 2026RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: Buy2,495,623$6.43
Feb 27, 2026Francis Chrisofficer: See RemarksSell15,294$15.00
Feb 27, 2026Francis Chrisofficer: See RemarksSell17,900$15.09
Feb 27, 2026Francis Chrisofficer: See RemarksOption17,900$3.87
Feb 27, 2026Francis Chrisofficer: See RemarksOption15,294$4.75
Feb 11, 2026BOLNO PAULdirector, officer: President and CEOGrant1,000,000$12.75
Feb 11, 2026Moran Kyleofficer: Chief Financial OfficerSell3,588$13.45
Feb 11, 2026Francis Chrisofficer: See RemarksGrant232,500$12.75
Feb 11, 2026BOLNO PAULdirector, officer: President and CEOSell10,480$13.45
Feb 11, 2026Francis Chrisofficer: See RemarksGrant38,750—
Feb 11, 2026Vargeese Chandraofficer: See RemarksGrant45,625—
Feb 11, 2026Francis Chrisofficer: See RemarksSell1,883$13.45
Feb 11, 2026Moran Kyleofficer: Chief Financial OfficerGrant273,750$12.75
Feb 11, 2026Vargeese Chandraofficer: See RemarksSell3,228$13.45
Feb 11, 2026Moran Kyleofficer: Chief Financial OfficerGrant45,625—
Feb 11, 2026BOLNO PAULdirector, officer: President and CEOGrant165,000—
Feb 11, 2026Vargeese Chandraofficer: See RemarksGrant273,750$12.75
Jan 6, 2026Francis Chrisofficer: See RemarksOption9,375$3.14
Jan 6, 2026Francis Chrisofficer: See RemarksSell1,295$16.70
Jan 6, 2026Francis Chrisofficer: See RemarksSell8,080$15.92
Dec 15, 2025GSK plc10 percent ownerBuy1,470,000$19.00
Dec 10, 2025Tan Aik NadirectorSell20,000$12.75
Dec 10, 2025Moran Kyleofficer: Chief Financial OfficerOption60,000$2.83
Dec 10, 2025Moran Kyleofficer: Chief Financial OfficerOption100,000$3.14
Dec 10, 2025Moran Kyleofficer: Chief Financial OfficerGrant50,000$4.75
Dec 10, 2025Moran Kyleofficer: Chief Financial OfficerSell50,000$15.00
Dec 10, 2025Moran Kyleofficer: Chief Financial OfficerSell36$20.25

Source: WVE SEC Form 4 filings, latest Mar 30, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their WVE positions over the last 6 months (SEC Form 13F).

Increased
204
New positions
109
Reduced
93
Sold out
73
Largest moves
InstitutionActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Increased27.0MMay 15, 2026
GSK PLCNew Position18.2MFeb 12, 2026
GSK PLCUnchanged18.2MMay 14, 2026
RA CAPITAL MANAGEMENT, L.P.Increased18.2MFeb 17, 2026
FMR LLCIncreased15.1MFeb 17, 2026
BLACKROCK, INC.Increased14.1MMay 13, 2026
BLACKROCK, INC.Increased12.6MFeb 12, 2026
MAVERICK CAPITAL LTDIncreased10.2MMay 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Reduced9.8MFeb 17, 2026
MAVERICK CAPITAL LTDIncreased9.3MFeb 13, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased8.7MMay 15, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased7.4MFeb 17, 2026
DARWIN GLOBAL MANAGEMENT, LTD.New Position7.3MFeb 17, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased6.6MFeb 17, 2026
M28 CAPITAL MANAGEMENT LPUnchanged5.7MFeb 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to WVE overview (price, financials, earnings)